SEC Tracker
Get the app
NTRB · XBRL financial data

NutriBand financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (NTRB's year ends in late January)

In thousands of dollarsOct 31, 2023Jan 31, 2024Apr 30, 2024Jul 31, 2024Oct 31, 2024Jan 31, 2025Apr 30, 2025Jul 31, 2025Oct 31, 2025Jan 31, 2026Apr 30, 2026Jul 31, 2026
Revenue428525*409443646642*667622346401*433438
Cost of revenue269343*244341455356*415466278312*237256
Cost of goods and services sold428525*——————————
Gross profit160181*165102191286*2521576989*——
Research and development552563*975774881490*683563457188*247322
Selling, general and administrative1,331924*1,0807377371,760*9821,5983,492922*1,204750
Total operating expenses1,9071,464*2,0541,5111,6185,845*1,6652,1603,9491,110*——
Operating income (loss)(1,724)(1,306)*(1,889)(1,410)(1,427)(5,559)*(1,413)(2,003)(3,880)(1,021)*(1,254)(891)
Interest income43*0776846*3191458*—15
Interest expense4023*9544*3665*55
Other income (expense)(36)(575)*(9)—————————
Net income (loss)(1,760)(1,881)*(1,898)(1,705)(1,363)(5,516)*(1,389)(2,000)(3,872)(968)*(1,242)(881)
Earnings per share, basic USD per share(0.22)(0.23)*(0.21)(0.15)(0.12)(0.50)*(0.12)(2.12)(0.32)(0.08)*(0.10)(0.07)
Earnings per share, diluted USD per share(0.22)(0.23)*(0.21)(0.15)(0.12)(0.50)*(0.12)(2.12)(0.32)(0.08)*(0.10)(0.07)
Weighted average shares, basic thousands of shares7,8338,313*9,16011,06211,10211,075*11,12611,21912,05712,146*12,15612,156
Weighted average shares, diluted thousands of shares7,8338,313*9,16011,06211,10211,075*11,12611,21912,05712,146*12,15612,156

Balance sheet

CSV

Fiscal quarters (NTRB's year ends in late January)

In thousands of dollarsOct 31, 2023Jan 31, 2024Apr 30, 2024Jul 31, 2024Oct 31, 2024Jan 31, 2025Apr 30, 2025Jul 31, 2025Oct 31, 2025Jan 31, 2026Apr 30, 2026Jul 31, 2026
Cash and cash equivalents1,2654938,3486,7605,6984,3122,9646,9955,3124,5754,0063,422
Accounts receivable17014985681107494161148118324
Inventory175169169224168212215138136118121171
Total current assets2,0001,0228,7307,2486,1924,7943,4307,5205,8154,9894,3763,819
Property and equipment, net767775740738740695658616588567548530
Right-of-use asset393124168—999081726354
Goodwill5,0225,0225,0225,0225,0221,7201,7201,7201,7201,7201,7201,720
Total assets8,5237,51715,15413,63412,5437,4706,15210,1778,4197,5486,8926,293
Total current liabilities7189991,4171,1041,2489839251,572773784832907
Total deposits250———————————
Lease liability, non-current9—————716456484032
Total liabilities2,8121,0791,7911,1731,3121,0411,0491,683870868902964
Accumulated deficit(26,099)(27,980)(29,878)(31,584)(32,946)(38,463)(39,852)(41,852)(45,724)(46,692)(47,934)(48,815)
Total stockholders' equity5,7116,43813,36312,46111,2326,4295,1038,4947,5496,6795,9905,329
Total liabilities and equity8,5237,51715,15413,63412,5437,4706,15210,1778,4197,5486,8926,293
Common shares outstanding (cover page) thousands of shares7,83310,97011,03611,09611,10611,15411,15412,03512,17512,15612,15612,156

Cash flows

CSV

Fiscal quarters (NTRB's year ends in late January)

In thousands of dollarsOct 31, 2023Jan 31, 2024Apr 30, 2024Jul 31, 2024Oct 31, 2024Jan 31, 2025Apr 30, 2025Jul 31, 2025Oct 31, 2025Jan 31, 2026Apr 30, 2026Jul 31, 2026
Net income (loss)(1,760)(1,881)*(1,898)(1,705)(1,363)(5,516)*(1,389)(2,000)(3,872)(968)*(1,242)(881)
Stock-based compensation338*0*423130*0*856*———99*552—
Depreciation and amortization68*69*6970*73*———————
Net cash from operating activities(1,064)*(718)*(834)(1,544)*(1,010)*(1,239)*(1,337)(1,313)*(1,752)*(732)*(563)(585)*
Purchases of property and equipment0*49*639*47*0*50*0*0*——
Net cash from investing activities0*(49)*(6)(39)*(47)*0*(5)0*0*0*——
Proceeds from issuing common stock————0*(5,846)*——0*0*——
Proceeds from issuing equity——8,4000*0*7*——————
Net cash from financing activities(5)*(5)*8,695(5)*(5)*(147)*(5)5,344*70*(5)*(6)0*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
NutriBand3,422438(585)*12.2M— 10-QJul 31, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026
Sintx Technologies3,590452(2,767)*6.7M1.3 quarters 10-QJun 30, 2026
Vycor Medical159418(4.8)*33.4M32.8 quarters 10-QJun 30, 2026
Harvard Apparatus Regenerative Technology351414(569)*17.6M0.6 quarters 10-QJun 30, 2026
Cerenome2,366411(7,132)*7.6M1.2 quarters 10-QJun 30, 2026
Family Office of America637533149*30.8M— 10-QJun 30, 2026
PetVivo Holdings123338(966)38.0M0.1 quarters 10-QJun 30, 2026
Femasys1,444332(3,936)*8.4M0.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.